These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19493022)

  • 21. Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism.
    Viaene L; Evenepoel P; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
    Nephron Clin Pract; 2008; 110(2):c80-5. PubMed ID: 18758187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
    Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
    J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets.
    Savio RM; Gosnell JE; Posen S; Reeve TS; Delbridge LW
    Arch Surg; 2004 Feb; 139(2):218-22. PubMed ID: 14769584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anesthesia and postoperative recovery for parathyroid gland surgery].
    Roland E
    Ann Chir; 1999; 53(2):150-61. PubMed ID: 10089669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M; Brancaccio D
    Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The hungry bone syndrome--an update].
    Farese S
    Ther Umsch; 2007 May; 64(5):277-80. PubMed ID: 17685087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroidectomy in the treatment of secondary hyperparathyroidism in chronic renal failure.
    Kostakis A; Vaiopoulos G; Kostantopoulos K; Zavos G; Bocos I; Sgouromalis S
    Int Surg; 1997; 82(1):85-6. PubMed ID: 9189811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased renal transplant function after parathyroidectomy.
    Schwarz A; Rustien G; Merkel S; Radermacher J; Haller H
    Nephrol Dial Transplant; 2007 Feb; 22(2):584-91. PubMed ID: 17035377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary and tertiary hyperparathyroidism].
    Kuriyama M; Yang M
    Nihon Rinsho; 1995 Apr; 53(4):965-7. PubMed ID: 7752493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid disorders.
    Michels TC; Kelly KM
    Am Fam Physician; 2013 Aug; 88(4):249-57. PubMed ID: 23944728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maxillary brown tumor in secondary hyperparathyroidism requiring urgent parathyroidectomy.
    Morrone LF; Ettorre GC; Passavanti G; Tampoia M; Schiavone P; Coratelli P
    J Nephrol; 2001; 14(5):415-9. PubMed ID: 11730277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
    Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
    Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide.
    Díaz-Soto G; Mora-Porta M; Nicolau J; Perea V; Halperin I; Puig-Domingo M
    Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive calcium monitoring improves outcomes on hungry bone syndrome in hyperparathyroidism.
    Ferreira JL; de Brito Marques F; Freire L; Soares V; Guerreiro L; Silva S; Guedes C
    Endocr Regul; 2021 Jan; 55(1):30-41. PubMed ID: 33600669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.